Balyasny Asset Management LLC Amgen Inc Put Options Transaction History

Balyasny Asset Management LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $2.01 Million - $2.19 Million	-6,500 Reduced 17.33%	31,000 $9.99 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $9.85 Million - $12 Million	37,500 New	37,500 $11.7 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $2.05 Million - $2.31 Million	8,000 New	8,000 $2.3 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $1.71 Million - $1.92 Million	7,600 Added 78.35%	17,300 $3.9 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $1.64 Million - $1.82 Million	7,100 Added 273.08%	9,700 $2.36 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $767,445 - $848,995	-3,500 Reduced 57.38%	2,600 $629,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $12.6 Million - $14 Million	-53,900 Reduced 89.83%	6,100 $1.49 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $4.69 Million - $5.22 Million	20,000 Added 50.0%	60,000 $15.3 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $6.33 Million - $7.77 Million	-32,000 Reduced 44.44%	40,000 $9.43 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $6.51 Million - $7.34 Million	-36,000 Reduced 33.33%	72,000 $13.7 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $9.9 Million - $11.6 Million	55,500 Added 105.71%	108,000 $21 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $9.73 Million - $11 Million	52,500 New	52,500 $10.7 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.